113 related articles for article (PubMed ID: 11992567)
21. Interleukin-6 gene polymorphism is an age-dependent risk factor for myocardial infarction in men.
Chiappelli M; Tampieri C; Tumini E; Porcellini E; Caldarera CM; Nanni S; Branzi A; Lio D; Caruso M; Hoffmann E; Caruso C; Licastro F
Int J Immunogenet; 2005 Dec; 32(6):349-53. PubMed ID: 16313298
[TBL] [Abstract][Full Text] [Related]
22. Association of the IL12RB1 promoter polymorphisms with increased risk of atopic dermatitis and other allergic phenotypes.
Takahashi N; Akahoshi M; Matsuda A; Ebe K; Inomata N; Obara K; Hirota T; Nakashima K; Shimizu M; Tamari M; Doi S; Miyatake A; Enomoto T; Nakashima H; Ikezawa Z; Shirakawa T
Hum Mol Genet; 2005 Nov; 14(21):3149-59. PubMed ID: 16159888
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-6 promoter polymorphism and late-onset Alzheimer's disease in the Finnish population.
Koivisto AM; Helisalmi S; Pihlajamäki J; Moilanen L; Kuusisto J; Laakso M; Hiltunen M; Keijo K; Hänninen T; Helkala EL; Kervinen K; Kesäniemi YA; Soininen H
J Neurogenet; 2005; 19(3-4):155-61. PubMed ID: 16540406
[TBL] [Abstract][Full Text] [Related]
24. Association of an interleukin-1beta gene polymorphism at position -511 with Alzheimer's disease.
Ehl C; Kölsch H; Ptok U; Jessen F; Schmitz S; Frahnert C; Schlösser R; Rao ML; Maier W; Heun R
Int J Mol Med; 2003 Feb; 11(2):235-8. PubMed ID: 12525884
[TBL] [Abstract][Full Text] [Related]
25. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
[TBL] [Abstract][Full Text] [Related]
26. Gene dose-dependent association of interleukin-1A [-889] allele 2 polymorphism with Alzheimer's disease.
Combarros O; Sánchez-Guerra M; Infante J; Llorca J; Berciano J
J Neurol; 2002 Sep; 249(9):1242-5. PubMed ID: 12242547
[TBL] [Abstract][Full Text] [Related]
27. Relationship between interleukin 6 promoter polymorphism at position -174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica.
Boiardi L; Casali B; Farnetti E; Pipitone N; Nicoli D; Cantini F; Macchioni P; Bajocchi G; Catanoso MG; Pulsatelli L; Consonni D; Salvarani C
J Rheumatol; 2006 Apr; 33(4):703-8. PubMed ID: 16583473
[TBL] [Abstract][Full Text] [Related]
28. Age at onset: an essential variable for the definition of genetic risk factors for sporadic Alzheimer's disease.
Beyer K; Lao JI; Latorre P; Ariza A
Ann N Y Acad Sci; 2005 Dec; 1057():260-78. PubMed ID: 16399900
[TBL] [Abstract][Full Text] [Related]
29. Association between the interleukin-1alpha gene and Alzheimer's disease: a meta-analysis.
Rainero I; Bo M; Ferrero M; Valfrè W; Vaula G; Pinessi L
Neurobiol Aging; 2004; 25(10):1293-8. PubMed ID: 15465625
[TBL] [Abstract][Full Text] [Related]
30. Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease.
Lio D; Licastro F; Scola L; Chiappelli M; Grimaldi LM; Crivello A; Colonna-Romano G; Candore G; Franceschi C; Caruso C
Genes Immun; 2003 Apr; 4(3):234-8. PubMed ID: 12700599
[TBL] [Abstract][Full Text] [Related]
31. Interleukin 6 -174 g/c promoter polymorphism and risk of coronary heart disease: results from the rotterdam study and a meta-analysis.
Sie MP; Sayed-Tabatabaei FA; Oei HH; Uitterlinden AG; Pols HA; Hofman A; van Duijn CM; Witteman JC
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):212-7. PubMed ID: 16269662
[TBL] [Abstract][Full Text] [Related]
32. A promoter polymorphism in the monoamine oxidase A gene is associated with the pineal MAOA activity in Alzheimer's disease patients.
Wu YH; Fischer DF; Swaab DF
Brain Res; 2007 Sep; 1167():13-9. PubMed ID: 17692293
[TBL] [Abstract][Full Text] [Related]
33. Association study and meta-analysis of low-density lipoprotein receptor related protein in Alzheimer's disease.
Pritchard A; Harris J; Pritchard CW; St Clair D; Lemmon H; Lambert JC; Chartier-Harlin MC; Hayes A; Thaker U; Iwatsubo T; Mann DM; Lendon C
Neurosci Lett; 2005 Jul; 382(3):221-6. PubMed ID: 15925094
[TBL] [Abstract][Full Text] [Related]
34. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease.
Cantor MJ; Nickerson P; Bernstein CN
Am J Gastroenterol; 2005 May; 100(5):1134-42. PubMed ID: 15842590
[TBL] [Abstract][Full Text] [Related]
35. Influence of the Pro12Ala polymorphism of PPAR-gamma on age at onset and sRAGE levels in Alzheimer's disease.
Yao L; Li K; Zhang L; Yao S; Piao Z; Song L
Brain Res; 2009 Sep; 1291():133-9. PubMed ID: 19631630
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-6 (IL-6) -572C-->G promoter polymorphism is associated with type 2 diabetes risk in Koreans.
Koh SJ; Jang Y; Hyun YJ; Park JY; Song YD; Shin KK; Chae JS; Kim BK; Ordovas JM; Lee JH
Clin Endocrinol (Oxf); 2009 Feb; 70(2):238-44. PubMed ID: 18573122
[TBL] [Abstract][Full Text] [Related]
37. [Apolipoprotein E gene polymorphisms and Alzheimer disease].
Chen D; Zhang JW; Zhang ZX; Zhao HL; Li XQ; Wu YN; Qu QM
Yi Chuan Xue Bao; 2003 Dec; 30(12):1167-70. PubMed ID: 14986436
[TBL] [Abstract][Full Text] [Related]
38. A polymorphism of the interleukin-1 beta gene at position +3953 influences progression and neuro-pathological hallmarks of Alzheimer's disease.
Licastro F; Veglia F; Chiappelli M; Grimaldi LM; Masliah E
Neurobiol Aging; 2004 Sep; 25(8):1017-22. PubMed ID: 15212826
[TBL] [Abstract][Full Text] [Related]
39. The interleukin-6 -174G/C promoter polymorphism is not associated with endometriosis in South Indian women.
Bhanoori M; Babu KA; Deenadayal M; Kennedy S; Shivaji S
J Soc Gynecol Investig; 2005 Jul; 12(5):365-9. PubMed ID: 15979549
[TBL] [Abstract][Full Text] [Related]
40. Effect of the APOE-491A/T promoter polymorphism on apolipoprotein E levels and risk of Alzheimer disease: The Rotterdam Study.
Roks G; Cruts M; Houwing-Duistermaat JJ; Dermaut B; Serneels S; Havekes LM; Hofman A; Breteler MM; Van Broeckhoven C; van Duijn CM
Am J Med Genet; 2002 Jul; 114(5):570-3. PubMed ID: 12116196
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
